Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
55
Publications avec texte intégral
Open Access
46 %
Mots clés
CTCF
Germinal center
Myoblasts
Conduction disease
Anticorps monoclonal
Adaptive immunity
Acetylcholine receptor
Auto-immunité
Cellules th17
Maladie auto-immune
Neuromuscular junction
Gd T cells
Glucocorticoids
Interferon de type I
Interleukine-23
Experimental autoimmune myasthenia gravis
CCL21
Interferon
Quality of life
CXCL13-CXCR5
Interferon-β
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Interferonopathy
Genetics
FMR1
Thymus
Acetylcholine receptors
Experimental models
Chronic inflammation
Cardiomyopathy
Endogenous nucleic acids
Myasthenia Gravis MG
Myasthénie grave
CD31
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Antimir-150
Acetylcholine receptor antibodies
Transcriptome
Interferon IFN
Thymoma
Max
Autoimmune diseases
Interferon type-I
MiR-7
Interféron de type I
Cytokines
Experimental mouse models
B cells
Immune response
MiR-125
Experimental autoimmune myasthenia gravis EAMG
Interleukin 23
Human myoblasts
Immunology and Microbiology Section
Acides nucléiques endogènes
Lamin A/C nuclei
Early-onset myasthenia gravis
Chemokine
Complete Freund's adjuvant
BAFF
Thymic epithelial cells
Ectopic germinal centers
Chemokines
Autoimmune disease
MG patients
Etiology
DICER
Clinical cell transplantation
Inflammation
Long-term follow-up
PBMC
AChR antibodies
Th17 cells
Il-23
Autoimmunity
Disease susceptibility
Inflammatory cytokines
Fragile X syndromes
Mass cytometry CyTOF
Macrophages
Chronicity
Heart failure
COX2
Interferon type I
M3243AG
Immunity
COVID-19
Exercise
Centres germinatifs ectopiques
Immunotherapy
Ferrites
LMNA
Genetic associations
Animal models
Myasthenia gravis
Innate immunity
MYB
Germinal centers
Immune regulation
Gender